• Home
  • About IBT
    • Vision and Mission
    • IBT History
    • Management
    • Board of Directors
    • Advisory Board
  • Families
    • Families
  • Health Care Professionals
  • Pipeline
    • IBP-9414
    • IBP-1016
  • Investors & Media
    • Shares
    • Presentations
    • Share Issue
    • Ownership Structure
    • Corporate Governance
    • Calendar
    • Financial Reports
    • Press Releases
    • News
    • Investors & Media Contact
    • Subscribe
  • Contact Us
  • Career
IBT Logo IBT Logo
  • En
  • Sv
  • Home
  • About IBT
    • Vision and Mission
    • IBT History
    • Management
    • Board of Directors
    • Advisory Board
  • Families
    • Families
  • Health Care Professionals
  • Pipeline
    • IBP-9414
    • IBP-1016
  • Investors & Media
    • Shares
    • Presentations
    • Share Issue
    • Ownership Structure
    • Corporate Governance
    • Calendar
    • Financial Reports
    • Press Releases
    • News
    • Investors & Media Contact
    • Subscribe
  • Contact Us
  • Career

Press releases


Outcome of Infant Bacterial Therapeutics’ rights issue

 

To access the press release, please read the following disclaimer here.

February 2, 2018

Latest press releases

Infant Bacterial Therapeutics receives additional patent protection in China
Infant Bacterial Therapeutics publishes Annual Report for 2020
Notice to attend the Annual General Meeting of Infant Bacterial Therapeutics
Infant Bacterial Therapeutics announces that the recruitment to the first stage of the Phase III Connection Study is completed – an update about the clinical development of IBP-9414
Infant Bacterial Therapeutics today announces that new patent protection is granted in Japan
This site uses cookies – small text-based files that are placed on your device to help us provide a better user experience. Find out more.
Contact | info@ibtherapeutics.com
© Copyright Infant Bacterial Therapeutics AB 2021
Cookie Policy Privacy Policy Terms of Use